MDS?

Alain Mina1, Peter L Greenberg2, H Joachim Deeg3

  • 1Myeloid Malignancies Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

Blood
|February 2, 2024
PubMed
概括

异构干细胞移植为高风险的骨髓发育综合征 (MDS) 提供了治疗方法. 在移植后管理MDS复发对于改善患者的治疗结果至关重要.